EyePoint (EYPT) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Powered by 
Analysis
EyePoint (EYPT) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.96% |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 | 51.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.62% |
| Mar 31, 2026 | 53.75% |
| Dec 31, 2025 | 87.90% |
| Sep 30, 2025 | 105.91% |
| Jun 30, 2025 | 99.05% |
| Mar 31, 2025 | 145.30% |
| Dec 31, 2024 | 158.03% |
| Sep 30, 2024 | 146.53% |
| Jun 30, 2024 | 137.50% |
| Mar 31, 2024 | 128.59% |
| Dec 31, 2023 | 102.75% |
| Sep 30, 2023 | 108.82% |
| Jun 30, 2023 | 91.05% |
| Mar 31, 2023 | 83.10% |
| Dec 31, 2022 | 56.18% |
| Sep 30, 2022 | 38.03% |
| Jun 30, 2022 | 38.63% |
| Mar 31, 2022 | 8.64% |
| Dec 31, 2021 | 18.23% |
| Sep 30, 2021 | 20.51% |